• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1128275-23
Device Problems Difficult to Remove (1528); Failure to Advance (2524); Device Damaged by Another Device (2915)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/12/2024
Event Type  malfunction  
Event Description
It was reported that the procedure was performed to treat a bifurcated lesion at the proximal-mid left anterior descending (lad) and the proximal left circumflex (lcx) coronary arteries with heavy calcification, mild tortuosity and 80% stenosis.The 2.75x38mm xience pro a stent was implanted in the proximal-mid lad.A 2.75x23 mm xience pro a stent delivery system (sds) was advanced to the ostium of the lcx, but was unable to cross the previously implanted xience pro a stent.During removal of the 2.75x23 mm xience pro a sds, the stent became entrapped by the previously implanted stent at the proximal lad.Both stents were then retrieved into the guiding catheter without any remnants.It was noted that the deployed stent was elongated.A new 3.0x28mm xience pro a stent was successfully implanted at the proximal lad and a new 2.75x23mm xience pro a stent was implanted at the lcx.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.The xience proa device is currently not commercially available in the us; however, it is similar to a device sold in the us.The additional xience proa device referenced in b5 is filed under separate medwatch report number.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
Subsequent to the initial reports, additional information was received confirming the 2.75x38mm xience pro a was implanted in the proximal / mid lad.When the 2.75x23mm xience pro a was advanced, it interacted with this previously implanted 2.75x38 mm stent.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18852790
MDR Text Key337075223
Report Number2024168-2024-02864
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeTH
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1128275-23
Device Lot Number3042741
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/18/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
2.75X38MM XIENCE PRO A
-
-